⌘K

Home/Filings/4/0001209191-20-020754

4//SEC Filing

Daruwala Paul 4

Accession 0001209191-20-020754

CIK 0001610618other

View on SEC.gov Company Profile

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 7:23 PM ET

Size

5.5 KB

Accession

0001209191-20-020754

Insider Transaction Report

Form 4

Period: 2020-03-19

Cidara Therapeutics, Inc.CDTX

Chief Medical Officer

Transactions

Award
Employee Stock Option (right to buy)
2020-03-19+90,000→ 90,000 total
Exercise: $1.98Exp: 2030-03-18→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19,2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1

filerCIK 0001639144

Filing Metadata

Form type: 4
Filed: Mar 22, 8:00 PM ET
Accepted: Mar 23, 7:23 PM ET
Size: 5.5 KB

View on SEC.gov